Irbesartan-hctz (2021-01-12)

Irbesartan-HCTZ Recall Summary Irbesartan-HCTZ, a blood pressure medication, has been recalled across Canada due to product safety concerns. This recall affects all patients who have been prescribed this medication. The recall is classified as Class I, which indicates a serious safety issue.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2021-01-12
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/157c85be-2b90-4ff8-b18e-29051a8f6415